Typhaneoside
Typhaneoside, extracted from Typha angustifolia L., Typhaneoside can inhibit the excessive autophagy of hypoxia/reoxygenation cells and increase the phosphorylation of Akt and mTOR. Typhaneoside has certain effects on the cardiovascular system, including lowering blood lipid levels, promoting antiatherosclerosis activities, as well as improving immune and coagulation function[1].
| Trivial name | / |
| Catalog Number | CSN25367 |
| Alternative Name(s) | / |
| Research Area | Cardiovascular Disease |
| Molecular Formula | C34H42O20 |
| CAS# | 104472-68-6 |
| Purity | ≥95% |
| SMILES | O=C1C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O[C@@]([C@@H]([C@@H]4O)O)(O[C@@H](C)[C@@H]4O)[H])O2)O)=C(C5=CC=C(O)C(OC)=C5)OC6=C1C(O)=CC(O)=C6 |
| Size | 50mg |
| Supplier Page | https://www.csnpharm.com/products/typhaneoside.html |